Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

September 28, 2023 21:00 (London Time)

OptiNose

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: OPTN
Sentiment: 0.7096
MarketCap: 140,279,146.0
High: 1.29 Low: 1.22

Open: 1.24 Close: 1.24 Change: 0.0

What an AI can tell you about OptiNose before investing.

The game is changing. There is a new strategy to evaluate OptiNose fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about OptiNose are: Praderwilli, syndrome, market, poise, extraordinary, growth, forecast, and the …

Concept Map

...

Semantic Network

...

Stock Summary

OptiNose, Inc. focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery.

Today's Summary

Prader-willi syndrome market poised for extraordinary growth during the forecast period (2023-32) Companies Actively Working in the Therapeutics Market Include Soleno Therapeutic Levo Therapecles, Inversago Pharma Saniona and others.

Today's News

Prader-willi syndrome market poised for extraordinary growth during the forecast period (2023-32) Companies Actively Working in the Therapeutics Market Include Soleno Therapeutic Levo Therapecles, Inversago Pharma Saniona and others.

Stock Profile

"OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. OptiNose, Inc. has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Orexia Therapeutics to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania."

Keywords

Are looking for the most relevant information about OptiNose? Investor spend a lot of time searching for information to make investment decisions in OptiNose. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about OptiNose are: Praderwilli, syndrome, market, poise, extraordinary, growth, forecast, and the most common words in the summary are: specialty, manufacturer, drug, generic, unlock, inc, nasdaq, . One of the sentences in the summary was: Prader-willi syndrome market poised for extraordinary growth during the forecast period (2023-32) Companies Actively Working in the Therapeutics Market Include Soleno Therapeutic Levo Therapecles, Inversago Pharma Saniona and others.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #specialty #manufacturer #drug #generic #unlock #inc #nasdaq.

Read more →

Related Results

...
January 21, 2024 17:49 (London Time)

OptiNose

Optinose hiring Territory Manager - Inland Empire, CA in Empire, California, United States.
Sector: Pharmaceuticals
Ticker: OPTN
Sentiment: 0.4215
MarketCap: 150,498,058.0
High: 1.36 Low: 1.28

Open: 1.33 Close: 1.36 Change: 0.03

Read more →
...
September 28, 2023 21:00 (London Time)

OptiNose

Prader-willi syndrome market poised for extraordinary growth during the forecast period (2023-32) Companies Actively Working in the Therapeutics Mar…
Sector: Pharmaceuticals
Ticker: OPTN
Sentiment: 0.7096
MarketCap: 140,279,146.0
High: 1.29 Low: 1.22

Open: 1.24 Close: 1.24 Change: 0.0

Read more →
...
October 23, 2023 6:43 (London Time)

OptiNose

OptiNose Inc. has reported a gross margin of 87.80 percent. The operating margin is currently at -66.60 percent and the profit margin is -93.20 perc…
Sector: Pharmaceuticals
Ticker: OPTN
Sentiment: -0.0516
MarketCap: 117,834,482.0
High: 1.12 Low: 1.02

Open: 1.04 Close: 1.05 Change: 0.01

Read more →
...
July 03, 2023 11:57 (London Time)

OptiNose

Optinose Inc 1,531 $1.23 $0.23 (0.00%) Today Watchers 1, 531 52-Wk Low $1,07 52- Wk High $4.30 Sentiment 0.00% Message Vol. Vol. 0OP stock price | o…
Sector: Pharmaceuticals
Ticker: OPTN
Sentiment: -0.4215
MarketCap: 137,705,748.0
High: 1.24 Low: 1.16

Open: 1.23 Close: 1.23 Change: 0.0

Read more →